The protocol
Every clinical study uses a protocol. This plan explains who may participate, what will happen during the study, how long it may last, and how researchers will collect and evaluate information.
Eligibility
Eligibility criteria help researchers identify people for whom a study may be appropriate. Criteria can include age, health history, current treatments, test results, and other factors related to the research question.
Informed consent is a conversation—not just a form.
The research team should explain the study in understandable language and give you an opportunity to ask questions before you decide whether to participate.
Common study phases
Phase 1
Researchers generally focus on safety, dosage, and how an investigational treatment behaves in the body.
Phase 2
Studies often examine whether a treatment shows evidence of benefit while continuing to evaluate safety.
Phase 3
Larger groups may be studied to confirm effectiveness, monitor side effects, and compare an investigational approach with existing care or a control.
Phase 4
Research may continue after approval to learn more about long-term use, effectiveness, or less common effects.
Your care and your choice
Ask how study participation may interact with your current care. Participation is voluntary, and you can ask about leaving the study at any time. A healthcare professional who knows your medical history can help you think through questions specific to your health.